$RKLB 20260402 72.0 CALL$ Rocket Lab’s stock soared last week due to a combination of high-value defense contracts and strategic expansion. The company secured a record $190 million deal for 20 hypersonic test flights and received German regulatory approval to acquire Mynaric AG, a move that integrates critical laser communication tech and establishes a European footprint. This momentum was further amplified by a successful dedicated mission for the European Space Agency and broader sector enthusiasm following reports of a massive valuation for its competitor, SpaceX.
Rocket Lab Clears $90 With $1.85B Backlog: Is $100 Within Reach?
Rocket Lab surged 3.92% past $90 as Benzinga reported sustained "Launch Squeeze" momentum with order backlog reaching $1.85B, reflecting structurally tight commercial launch supply being priced into the stock. SeekingAlpha positions RKLB as a strategic placeholder ahead of a potential SpaceX IPO, while Stifel's $105 price target — approximately 17% above current levels — provides institutional cover for further upside.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments